Brief: Lumos Diagnostics Says Got Interim Order Authorization From Health Canada For Its Viradx RAT
27/06/2022 02:28
June 27 (Reuters) - Lumos Diagnostics Holdings Ltd LDX.AX :
* GOT INTERIM ORDER AUTHORIZATION FROM HEALTH CANADA FOR ITS
VIRADX RAPID ANTIGEN TEST FOR COVID-19/FLU A/FLU B IN CANADA
Source text for Eikon: ID:nASX8YdBZx
Further company coverage: LDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lumos Diagnostics Holdings
See all newsBrief: Lumos Diagnostics Posts FY26 Revenue Of $13.2 Million
Australia's Lumos Diagnostics soars on bagging purchase order for diagnostic test
Brief: Lumos Diagnostics Receives $767,800 Febridx Order From Phase Scientific
Brief: Lumos Diagnostics Signs Exclusive Distribution Agreement For Febridx In Romania
Brief: Lumos Diagnostics Posts FY26 Revenue Rises 6% To $13.2 Million